| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |